CN Patent

CN103298832A — Actriia结合剂及其用途

Assigned to Acceleron Pharma Inc · Expires 2013-09-11 · 13y expired

What this patent protects

除了其它方面以外，本公开内容提供了结合ActRIIA的中和抗体及其部分以及它们的用途。

USPTO Abstract

除了其它方面以外，本公开内容提供了结合ActRIIA的中和抗体及其部分以及它们的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN103298832A
Jurisdiction
CN
Classification
—
Expires
2013-09-11
Drug substance claim
No
Drug product claim
No
Assignee
Acceleron Pharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.